Stoke Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Stoke Therapeutics

10/05/2022 14:12

* Stoke Therapeutics Inc  STOK.OQ  reported a quarterly
adjusted
loss of 66 cents​​ per share for the quarter ended in March. The
mean expectation of nine analysts for the quarter was
for earnings of 36 cents per share.
    * Revenue was $3.00 million​;  analysts expected $40.00
million. 
    * Stoke Therapeutics Inc's reported EPS for the quarter was
a loss
of 66 cents​.
    * The mean earnings estimate of analysts had risen by
about 424.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Stoke Therapeutics Inc shares had fallen by 39.7% this
quarter and lost 47.1% so far this year.
    * The company reported a quarterly loss of $24.65 million.
    * Wall Street's median 12-month price target for Stoke
Therapeutics Inc is $65.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 01:12 p.m.  ​All
figures in US dollars unless otherwise stated